Pharma-Bio Serv, Inc.
PBSV · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -44% | -12.5% | -3.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 26.5% | 29.8% | 25.2% | 26.6% |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | -11.6% | 7.7% | 6.3% | -18.8% |
| Net Income | -$0 | $0 | $0 | -$0 |
| % Margin | -8.2% | 7.7% | 5.2% | -10.4% |
| EPS Diluted | -0.034 | 0.057 | 0.044 | -0.091 |
| % Growth | -159.5% | 30.4% | 148.2% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |